Answers are grounded in this paper and cite their sources.
This research shows potent antibacterial activity against Staphylococcus aureus and Escherichia coli, suggesting green synthesized silver nanoparticles may combat antimicrobial resistance.
The global rise of antimicrobial resistance (AMR) poses a severe threat to public health, with multidrug-resistant pathogens undermining the efficacy of conventional antibiotics. Silver nanoparticles (AgNPs) have emerged as promising broad-spectrum antimicrobial agents. Here, we report a gamma radiation-assisted green synthesis of polyvinylpyrrolidone (PVP) or polyvinyl alcohol (PVA)-stabilized AgNPs, enabling rapid, sterile production of highly pure, uniformly dispersed nanoparticles without toxic byproducts, adapted for biomedical applications. Notably, AgNPs derived from Ag₂SO₄ precursor exhibited superior optical properties, and smaller homogeneous particle sizes compared to those from conventional AgNO₃. Optimized PVP-AgNPs demonstrated a well-known surface plasmon resonance near 396 nm, with sizes in the range of 5-25 nm as observed by transmission electron microscope, and a hydrodynamic diameter of ~ 33 nm. The physicochemical characterization of AgNPs was performed via different techniques such as X-ray photoelectron spectroscopy and powder X-ray diffraction. Importantly, PVP-/PVA-AgNPs displayed potent antibacterial activity, with minimum inhibitory concentrations of ~ 1 and 1-2 mg/L against Staphylococcus aureus, respectively, and 0.5 mg/L against Pseudomonas aeruginosa and Escherichia coli. These findings highlight the potential of green, radiation-synthesized AgNPs as a promising platform for next-generation antimicrobial materials in medical applications.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: